Publications by authors named "William Grosh"

Claim this Profile
P
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64).
Rick Daniel Vavolizza, Gina R Petroni, Ileana S Mauldin, Kimberly A Chianese-Bullock, Walter C Olson, William W Grosh

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.
Max O Meneveau, Gina R Petroni, Elise P Salerno, Kevin T Lynch, Mark Smolkin, William W Grosh

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of metastatic pancreatoblastoma in an adult with autologous hematopoietic cell transplant.
Omar Elghawy, John S Wang, Rachel M Whitehair, William Grosh, Tamila L Kindwall-Keller

Pancreatology· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, Nolan A Wages, Walter C Olson, William W Grosh

J Immunother Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
Eric Liu, Scott Paulson, Anthony Gulati, Jon Freudman, William Grosh

Oncologist· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
Marit M Melssen, Gina R Petroni, Kimberly A Chianese-Bullock, Nolan A Wages, William W Grosh

J Immunother Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for a change and to adopt a novel molecular genomic approach in NETs.
Lisa Bodei, Eric Liu, Scott Paulson, Anthony Gulati, Jon Freudman, William Grosh

Nat Rev Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor Therapy.
Donald L Kimpel, Janet E Lewis, Elizabeth Gaughan, William W Grosh, Christiana Brenin

J Clin Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.
Craig L Slingluff, Gina R Petroni, Walter C Olson, Mark E Smolkin, Kimberly A Chianese-Bullock, William W Grosh

Cancer Immunol Immunother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant gastrointestinal neuroectodermal tumour of the oesophagus with pulmonary metastasis and protracted survival.
Akeesha A Shah, William W Grosh, Henry F Frierson

Histopathology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated intravascular coagulation and immune hemolytic anemia, possibly Evans syndrome, after oxaliplatin and bevacizumab infusion for metastatic colon adenocarcinoma: a case report and literature review.
Lingjin Meng, Andrew Romano, Elliot Smith, Gail Macik, William W Grosh

Clin Colorectal Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.
Yinin Hu, Gina R Petroni, Walter C Olson, Andrea Czarkowski, Mark E Smolkin, William W Grosh

Cancer Immunol Immunother· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes.
Patrick M Dillon, Walter C Olson, Andrea Czarkowski, Gina R Petroni, Mark Smolkin, William W Grosh

J Immunother Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence.
Joshua M Judge, Louis B Brill, Kelly T Smith, Donna H Deacon, James W Patterson, William W Grosh

Cancer Immunol Immunother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
Craig L Slingluff, Gina R Petroni, Kerrington R Molhoek, David L Brautigan, Kimberly A Chianese-Bullock, William W Grosh

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.
Geoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, Yingdong Zhao, Hui Liu

Clin Cancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, Mark E Smolkin, Merrick I Ross, William W Grosh

J Clin Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines.
Craig L Slingluff, Gina R Petroni, Mark E Smolkin, Kimberly A Chianese-Bullock, Kelly Smith, William W Grosh

J Immunother· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary pericardial malignant mesothelioma and response to radiation therapy.
Kelli A Reardon, Michael A Reardon, Christopher A Moskaluk, William W Grosh, Paul W Read

Rare Tumors· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.
Kristin Turza, Lynn T Dengel, Rebecca C Harris, James W Patterson, Kevin White, William W Grosh

J Cutan Pathol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.
Craig L Slingluff, Gina R Petroni, Walter C Olson, Mark E Smolkin, Merrick I Ross, William W Grosh

Clin Cancer Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Craig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, William W Grosh, David W Mullins

Adv Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines.
Craig L Slingluff, Galina V Yamshchikov, Kevin T Hogan, Sarah C Hibbitts, Gina R Petroni, William W Grosh

Ann Surg Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens.
Craig L Slingluff, Gina R Petroni, Walter Olson, Andrea Czarkowski, William W Grosh

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, Mark E Smolkin, Sarah Hibbitts, William W Grosh

Clin Cancer Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis